Medical News

RSS

Newgen acquires novel oncology development programs from Kanion

NewGen Therapeutics, Inc. today announced the acquisition of three novel oncology development programs from Kanion USA, Inc. and Kanion Pharmaceutical Co., Ltd..

19 Dec 2011

Lixte's LB-205 shows therapeutic potential against Gaucher disease

An article in the early edition (December 12, 2011) of the Proceedings of the National Academy of Sciences USA, reported that Lixte's investigational drug, LB-205, was shown to have therapeutic potential in a laboratory model of Gaucher disease.

19 Dec 2011

American Anesthesiology acquires Burlington Anesthesia Associates

American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia Associates, a physician group practice that provides anesthesia services in Mt. Holly, NJ.

19 Dec 2011

GreatCall launches new app to make medication management easy

GreatCall, Inc., a leader in wireless services that enable people to stay connected, safe and healthy, today announced the immediate availability of its first Android OS application, MedCoach—a new app designed to make medication management easy for everyone.

19 Dec 2011

ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS

The ALS Therapy Development Institute today announced a research agreement with Biogen Idec and UCB Pharma SA to investigate the use of an anti-CD40L antibody as a potential therapy for Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's or Motor Neuron Disease.

19 Dec 2011

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

Alkermes plc today announced the initiation of a phase 3 clinical trial of ALKS 9070 for the treatment of schizophrenia. ALKS 9070, a proprietary Alkermes molecule, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY for the treatment of a number of central nervous system disorders.

19 Dec 2011

New gel could nip Lyme borreliosis infection in the bud

They come out in the spring, and each year they spread further - the ticks. Thirty percent of them transmit borrelia pathogens, the causative agent of Lyme borreliosis that can damage joints and organs.

19 Dec 2011

Halcyon Healthcare acquires Compassionate Hospice and Altus Healthcare & Hospice

Halcyon Healthcare, a portfolio company of Health Evolution Partners, announced today the completion of two hospice acquisitions in central and northern Georgia. The acquired companies, Compassionate Hospice and Altus Healthcare & Hospice, mark the first two transactions for Halcyon. Halcyon was formed in 2010 by HEP, Dan Kohl and Jack Draughon to build a leading hospice and home health company in the Southeastern U.S.

19 Dec 2011

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.

19 Dec 2011

Zimmer board approves quarterly cash dividend and new share repurchase program

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2012.

19 Dec 2011

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of Z944, a novel oral T-type calcium channel blocker with demonstrated preclinical potential for the treatment of acute and inflammatory pain.

19 Dec 2011

Soybean compounds can increase effectiveness of radiation treatment for lung cancer

A Wayne State University researcher has shown that compounds found in soybeans can make radiation treatment of lung cancer tumors more effective while helping to preserve normal tissue.

19 Dec 2011

Patheon fourth quarter revenues increase to $181.6 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today full year and fourth quarter results.

19 Dec 2011

First Edition: December 19, 2011

In today's headlines, the tax cut extension bill -- which includes a temporary Medicare 'doc fix' -- has hit a new snag.

19 Dec 2011

Acacia increases infusion pump technology patent portfolio

Acacia Research Corporation announced that a subsidiary has acquired patents relating to infusion pump technology from a major medical device company.

19 Dec 2011

DDC acquires Orchid Cellmark's government paternity business

DDC (DNA Diagnostics Center), one of the largest DNA testing companies in the world, announced today the acquisition of Orchid Cellmark, Inc.'s government paternity business.

19 Dec 2011

IGN joins BCCA Genome Science Center

Illumina, Inc. today announced that the British Columbia Cancer Agency's (BCCA) Genome Science Center has joined the Illumina Genome Network (IGN). IGN is designed to link researchers needing large-scale whole human genome sequencing with leading institutions that provide this application as a service using industry-leading Illumina sequencing platforms.

19 Dec 2011

TeleTracking releases Capacity Management Suite system version 2.3

TeleTracking Technologies today announced release of its Capacity Management Suite system version 2.3, which allows users to control core patient flow automation functions from an Apple iPad, streamline sign-on protocol for faster login, and speed responses to unexpected spills.

19 Dec 2011

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Pacira Pharmaceuticals, Inc. today announced the publication of data from a placebo-controlled, pivotal Phase 3 trial of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid local analgesic that was recently approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

19 Dec 2011

Toshiba, AHRA announce recipients of fourth annual Putting Patients First grant program

Helping hospitals, imaging centers and health systems develop or improve existing education and patient care initiatives in diagnostic imaging, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the seven recipients of the fourth annual Putting Patients First grant program.

19 Dec 2011